Could a pill curb aggression in fragile x? new trial aims to find out

NCT ID NCT07328529

First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 14 times

Summary

This study tests whether the drug SRX246 can reduce irritability, aggression, and self-injury in adult men with Fragile X Syndrome. About 80 participants will take either the drug or a placebo daily for up to 8 months, with regular check-ins by phone or home visits. The goal is to see if the drug improves behavior and is safe to use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGGRESSIVE BEHAVIOR IN FRAGILE X SYNDOME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cincinnati Children's Hospital

    Cincinnati, Ohio, 45229, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California, Davis, MIND Institute

    Sacramento, California, 95817, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.